In conversations with entrepreneurs starting or running companies in the women’s health space, I’ve heard a few of the same major challenges echoed: there’s not enough research, not enough education/awareness and not enough funding.
A new report from research firm Frost & Sullivan proposes that collaboration between public and private sectors is a critical factor in spurring investment and bringing new innovations in menstruation, contraception, maternal health, child birth, menopause and breast cancer to market.
To read the original article: Are investors helping breathe new life into the women’s health market? | MedCity News
